These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7983997)

  • 21. Isochromosome for derivative 17q in acute promyelocytic leukemia: evidence for two copies of PML-RARA and favorable response to all-trans-retinoic acid therapy.
    Park JP; Fairweather RB; Mohandas TK
    Genes Chromosomes Cancer; 1997 Feb; 18(2):151-3. PubMed ID: 9115966
    [No Abstract]   [Full Text] [Related]  

  • 22. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
    Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
    J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differentiation therapy of leukemia].
    Ono R
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1574-8. PubMed ID: 8537771
    [No Abstract]   [Full Text] [Related]  

  • 24. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
    Kitamura K; Takeshita A; Ono R; Naoe T
    Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
    [No Abstract]   [Full Text] [Related]  

  • 25. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C; Dejean A
    Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated efficacy of all-trans-retinoic acid in an acute promyelocytic leukemia patient.
    Watanabe A; Inokuchi K; Mizuki T; Yamaguchi H; Yokose N; Dan K
    Am J Hematol; 2000 Sep; 65(1):87-8. PubMed ID: 10936873
    [No Abstract]   [Full Text] [Related]  

  • 29. ATRA is effective to an acute promyelocytic leukemia patient without RARA gene rearrangement.
    Song X; Gong S; Chen J; Gao L; Yang J; Wang J
    Leuk Res; 2010 Aug; 34(8):e190-3. PubMed ID: 20189646
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel
    Li J; Zhang Y; Li J; Xu Y; Zhang G
    Haematologica; 2023 Feb; 108(2):627-632. PubMed ID: 36300779
    [No Abstract]   [Full Text] [Related]  

  • 31. The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease.
    Grimwade D
    Br J Haematol; 1999 Sep; 106(3):591-613. PubMed ID: 10468848
    [No Abstract]   [Full Text] [Related]  

  • 32. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
    Rashidi A; Fisher SI
    Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of retinoic acid receptor-target genes during retinoic acid therapy for acute promyelocytic leukemia.
    Takitani K; Koh M; Zhu CL; Inoue A; Kuno T; Tanoue H; Miyake M; Nakagawa T; Tamai H
    Leukemia; 2003 Mar; 17(3):646-8. PubMed ID: 12646960
    [No Abstract]   [Full Text] [Related]  

  • 35. A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation.
    Wells RA; Hummel JL; De Koven A; Zipursky A; Kirby M; Dubé I; Kamel-Reid S
    Leukemia; 1996 Apr; 10(4):735-40. PubMed ID: 8618456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APL, a model disease for cancer therapies?
    de Thé H; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
    [No Abstract]   [Full Text] [Related]  

  • 37. Retinoic acid and its rearranged receptor in the etiology and treatment of acute promyelocytic leukemia.
    Frankel SR; Miller WH; Dmitrovsky E
    Oncology (Williston Park); 1992 Aug; 6(8):74-78, 83; discussion 84, 87-8. PubMed ID: 1323988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
    Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
    Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New strategy for diagnosis and treatment of acute promyelocytic leukemia with t (15;17)].
    Kubo K; Naoe T; Fukutani H; Ohno R
    Rinsho Ketsueki; 1994 Mar; 35(3):250-5. PubMed ID: 8158844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-trans retinoic acid in myelogenous leukaemia.
    Gallagher RE; Wiernik PH
    Lancet; 1991 Dec 21-28; 338(8782-8783):1603. PubMed ID: 1684016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.